Sung Chan Park

Papers

Total Citations

397

H-Index

About

Dr. Sung Chan Park is a leading colorectal surgeon whose research has fundamentally shaped the modern surgical management of rectal cancer. His primary focus lies in comparing the clinical efficacy of robot-assisted surgery versus traditional laparoscopic techniques, particularly in complex oncologic settings. Dr. Park’s landmark 2017 Phase II randomized controlled trial, cited over 335 times, provided critical evidence on the comparative outcomes of these two minimally invasive approaches, directly addressing the unresolved question of robotic surgery’s feasibility for rectal cancer. His earlier 2015 case-matched study, with 62 citations, further advanced the field by demonstrating the short-term safety and advantages of robotic surgery specifically for patients who had undergone preoperative chemoradiotherapy—a high-risk and challenging cohort. Through these rigorous comparative effectiveness studies, Dr. Park has helped define the role of robotic platforms in improving patient recovery and surgical precision. His work remains essential reading for surgeons and researchers evaluating the evolution of minimally invasive colorectal surgery and its impact on oncologic outcomes.